HI
AZN icon

Hudock Inc’s AstraZeneca AZN Stock Holding History

Hudock Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Buy
+1,838
New +$346K 0.04% 161
2026
Q1 		– Sell
-1,841
Closed -$339K – 201
2025
Q4 		$339K Buy
1,841
+8
+0.4% +$1.4K 0.05% 146
2025
Q3 		$281K Buy
1,833
+31
+2% +$4.69K 0.04% 159
2025
Q2 		$252K Hold
1,802
– – 0.04% 161
2025
Q1 		$265K Hold
1,802
– – 0.05% 144
2024
Q4 		$236K Hold
1,802
– – 0.04% 150
2024
Q3 		$281K Hold
1,802
– – 0.05% 138
2024
Q2 		$281K Buy
1,802
+200
+12% +$30.1K 0.05% 129
2024
Q1 		$217K Sell
1,602
-246
-13% -$32.6K 0.05% 132
2023
Q4 		$249K Hold
1,848
– – 0.05% 135
2023
Q3 		$250K Sell
1,848
-125
-6% -$17.1K 0.06% 131
2023
Q2 		$282K Buy
1,973
+285
+17% +$41.9K 0.07% 123
2023
Q1 		$234K Sell
1,688
-150
-8% -$20.2K 0.06% 137
2022
Q4 		$249K Sell
1,838
-43
-2% -$5.39K 0.09% 123
2022
Q3 		$206K Buy
1,881
+1
+0.1% +$127 0.07% 133
2022
Q2 		$248K Hold
1,880
– – 0.08% 115
2022
Q1 		$249K Buy
1,880
+2
+0.1% +$240 0.07% 130
2021
Q4 		$218K Hold
1,878
– – 0.06% 151
2021
Q3 		$225K Buy
1,878
+195
+12% +$22.7K 0.07% 143
2021
Q2 		$201K Hold
1,683
– – 0.06% 150
2021
Q1 		$167K Sell
1,683
-316
-16% -$31.8K 0.05% 152
2020
Q4 		$199K Sell
1,999
-312
-14% -$33K 0.06% 141
2020
Q3 		$253K Hold
2,311
– – 0.09% 103
2020
Q2 		$244K Buy
2,311
+632
+38% +$65.3K 0.09% 101
2020
Q1 		$149K Buy
1,679
+1
+0.1% +$94 0.06% 115
2019
Q4 		$169K Hold
1,678
– – 0.06% 121
2019
Q3 		$149K Buy
1,678
+1
+0.1% +$87 0.05% 126
2019
Q2 		$138K Sell
1,677
-1,000
-37% -$78.4K 0.05% 129
2019
Q1 		$216K Sell
2,677
-122
-4% -$9.62K 0.08% 101
2018
Q4 		$211K Sell
2,799
-249
-8% -$19.4K 0.09% 96
2018
Q3 		$241K Buy
3,048
+2
+0.1% +$151 0.09% 86
2018
Q2 		$213K Hold
3,046
– – 0.08% 96
2018
Q1 		$213K Sell
3,046
-312
-9% -$21.6K 0.09% 104
2017
Q4 		$233K Hold
3,358
– – 0.1% 96
2017
Q3 		$227K Sell
3,358
-29
-0.9% -$1.83K 0.11% 76
2017
Q2 		$230K Hold
3,387
– – 0.12% 82
2017
Q1 		$210K Buy
3,387
+14
+0.4% +$815 0.11% 85
2016
Q4 		$184K Sell
3,373
-290
-8% -$16.5K 0.1% 102
2016
Q3 		$240K Sell
3,663
-408
-10% -$26.7K 0.14% 83
2016
Q2 		$245K Buy
4,071
+1,049
+35% +$60.9K 0.13% 82
2016
Q1 		$170K Buy
3,022
+11
+0.4% +$661 0.09% 101
2015
Q4 		$204K Hold
3,011
– – 0.09% 92
2015
Q3 		$191K Hold
3,011
– – 0.09% 90
2015
Q2 		$191K Hold
3,011
– – 0.09% 95
2015
Q1 		$206K Hold
3,011
– – 0.09% 92
2014
Q4 		$212K Sell
3,011
-475
-14% -$34K 0.1% 92
2014
Q3 		$249K Sell
3,486
-650
-16% -$47.6K 0.15% 94
2014
Q2 		$307K Sell
4,136
-3,614
-47% -$261K 0.35% 60
2014
Q1 		$503K Sell
7,750
-550
-7% -$35.5K 0.42% 38
2013
Q4 		$493K Buy
8,300
+100
+1% +$5.43K 0.42% 37
2013
Q3 		$426K Buy
8,200
+775
+10% +$38.9K 0.41% 37
2013
Q2 		$351K Buy
+7,425
New +$378K 0.52% 44

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hudock Inc's AZN Position: Q2 2026 in Review

Hudock Inc opened a new position in AstraZeneca (AZN) in Q2 2026: 1,838 shares worth $345K. The stake represents 0.04% of the portfolio and ranks #161 among its holdings. This is a return to the name: Hudock Inc previously reported a position in AZN as recently as Q4 2025.

Hudock Inc first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $503K in Q1 2014. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Hudock Inc held 1,838 shares of AstraZeneca worth $345K as of Q2 2026.
  • AstraZeneca was a new Hudock Inc position in Q2 2026.
  • AstraZeneca made up 0.04% of Hudock Inc's portfolio in Q2 2026, its #161 holding.
  • Hudock Inc first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
  • Hudock Inc's AstraZeneca position peaked at $503K in Q1 2014.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hudock Inc's 13F filing for Q2 2026, filed 31 Jul 2026.